These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2285165)

  • 1. [Plasminogen depletion and incorporation in experimental venous thrombosis].
    Fontcuberta J; Latorre J; Rosendo A; Elez I
    Angiologia; 1990; 42(5):159-66. PubMed ID: 2285165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated derivatives of streptokinase-plasminogen activator complex as thrombolytic agents in a dog model of aged venous thrombosis.
    Dupe RJ; Green J; Smith RA
    Thromb Haemost; 1985 Feb; 53(1):56-9. PubMed ID: 3887635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin generation in dogs with venous thrombosis.
    Takeda Y
    J Lab Clin Med; 1971 Dec; 78(6):1002-3. PubMed ID: 4257106
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioiodinated plasminogen: an imaging agent for pre-existing thrombi.
    Harwig SL; Harwig JF; Sherman LA; Coleman RE; Welch MJ
    J Nucl Med; 1977 Jan; 18(1):42-5. PubMed ID: 830827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)].
    Verstraete M
    J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of labelled monocytes by experimental venous thrombi.
    McGuinness CL; Humphries J; Waltham M; Burnand KG; Collins M; Smith A
    Thromb Haemost; 2001 Jun; 85(6):1018-24. PubMed ID: 11434678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen uptake by thrombi: effect of thrombus age.
    Coleman RE; Harwig SS; Harwig JF; Siegel BA; Welch MJ
    J Nucl Med; 1975 May; 16(5):370-3. PubMed ID: 1194988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis.
    Linkins LA; Stretton R; Probyn L; Kearon C
    Thromb Res; 2006; 117(3):241-7. PubMed ID: 16378830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
    Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
    Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model.
    Wolf RF; Gilmore LS; Friese P; Downs T; Burstein SA; Dale GL
    Thromb Haemost; 1997 May; 77(5):1020-4. PubMed ID: 9184421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
    Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
    Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-life improvement using thrombolytic therapy for iliofemoral deep venous thrombosis.
    Comerota AJ
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S61-7. PubMed ID: 12556744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombus formation in deep venous thrombosis. A clinical approach to diagnosis and control of lysis efficacy.
    Scheffler P; Leipnitz G; Braun B; Jung F; De La Hamette D; Kramann B; Wenzel E
    Int Angiol; 1988; 7(3):207-13. PubMed ID: 3058831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.